Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This study looked at a type of immunotherapy to help delay or prevent non small cell lung cancer (NSCLC) coming back after surgery.
Recruitment start: 1 November 2007
Recruitment end: 31 December 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ernie Marshall
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 21 Aug 2017
CRUK internal database number: 2453